Filing Details
- Accession Number:
- 0001144204-14-010092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-14 21:00:25
- Reporting Period:
- 2014-02-12
- Filing Date:
- 2014-02-14
- Accepted Time:
- 2014-02-14 21:00:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1559537 | Paolo Fundaro | C/O Intercept Pharmaceuticals, Inc. 450 W. 15Th Street, Suite 505 New York NY 10011 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-12 | 3,461 | $8.67 | 5,440 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-12 | 3,461 | $8.67 | 8,901 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-12 | 500 | $368.17 | 8,401 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 1,500 | $370.00 | 6,901 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 500 | $372.00 | 6,401 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 500 | $373.00 | 5,901 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 1,000 | $375.00 | 4,901 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 864 | $378.66 | 4,037 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 136 | $379.79 | 3,901 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 500 | $381.00 | 3,401 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 500 | $382.00 | 2,901 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 922 | $383.00 | 1,979 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-14 | 324 | $367.51 | 1,655 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options to Purchase Common Stock | Disposition | 2014-02-12 | 3,461 | $0.00 | 3,461 | $8.67 |
Common Stock | Options to Purchase Common Stock | Disposition | 2014-02-12 | 3,461 | $0.00 | 3,461 | $8.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-10-13 | No | 4 | M | Direct | |
0 | 2021-10-13 | No | 4 | M | Direct |
Footnotes
- The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 5, 2013.
- The shares of common stock underlying this option are fully vested.
- This transaction was executed in multiple trades at prices ranging from $368.01 to $368.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $378.2 to $379. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $379.22 to $380. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.